New program aims to cut HIV stigma and risk for drug users in kyrgyzstan
NCT ID NCT07541131
First seen Apr 23, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This study tests a program called LIFT to reduce HIV risk and stigma among 80 people who inject drugs in Kyrgyzstan. Participants join peer-led group sessions to build support and learn how to better access HIV services. The goal is to see if the program lowers stigma and increases use of HIV prevention tools like PrEP and medication for opioid use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV - HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Public Foundation Den Sooluk Nuru
Bishkek, Kyrgyzstan
Conditions
Explore the condition pages connected to this study.